In MPN, mutant CALR interacts with the thrombopoietin receptor (MPL/TPOR) promoting direct dimerization and activation of JAK2 at the endoplasmic reticulum (ER)–Golgi apparatus. This evidence concerns the gene MPL and myeloproliferative neoplasm.